As of September 2024, BioLineRx has a market cap of $50.14M. This makes BioLineRx the world's 25173th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $81.05M | -27.23% |
2023 | $111.36M | 172.86% |
2022 | $40.81M | -67.59% |
2021 | $125.94M | -21.60% |
2020 | $160.63M | 2.42% |
2019 | $156.84M | -67.05% |
2018 | $476.07M | -56.90% |
2017 | $1.10B | 9.04% |
2016 | $1.01B | -32.08% |
2015 | $1.49B | -20.56% |
2014 | $1.88B | -34.42% |
2013 | $2.86B | 4.36% |
2012 | $2.74B | -17.74% |
2011 | $3.34B | -64.36% |
2010 | $9.36B | -16.28% |
2009 | $11.18B | 361.93% |
2008 | $2.42B | -78.83% |
2007 | $11.43B | - |